Journal of pain & palliative care pharmacotherapy
-
In conjunction with World Cancer Day 2012, three leading pain and palliative care organizations developed a statement on access to analgesics to provide freedom from pain as a human right. Numerous other professional organizations subsequently signed this manifesto calling upon governments, the pharmaceutical industry, and health institutions to make available immediate-release morphine at affordable prices for all in need of pain relief. This report is reprinted with permission of the originating organizations. For more information see: http://palliumindia.org/manifesto/.
-
J Pain Palliat Care Pharmacother · Jun 2012
Shared risk evaluation mitigation strategy for all immediate-release transmucosal fentanyl dosage forms.
The Food and Drug Administration approved a single shared Risk Evaluation Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl dosage forms in December 2011. This report describes the goals, elements, and restricted distribution system of the REMS designed to reduce risk of abuse, misuse, addiction, and overdose with the drugs. Questions and answers about REMS also are presented. ⋯ That announcement is accessible at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm285345.htm. Concurrently the FDA posted a series of questions and answers on this shared REMS at: http://http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm284717.htm. Both documents are in the public domain.